GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (FRA:9GM0) » Definitions » 12-1 Month Momentum %

G Medical Innovations Holdings (FRA:9GM0) 12-1 Month Momentum % : -98.37% (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-24), G Medical Innovations Holdings's 12-1 Month Momentum % is -98.37%.

The industry rank for G Medical Innovations Holdings's 12-1 Month Momentum % or its related term are showing as below:

FRA:9GM0's 12-1 Month Momentum % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -18.55 vs FRA:9GM0: -98.37

Competitive Comparison of G Medical Innovations Holdings's 12-1 Month Momentum %

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's 12-1 Month Momentum % falls into.



G Medical Innovations Holdings  (FRA:9GM0) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings  (FRA:9GM0) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


G Medical Innovations Holdings 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (FRA:9GM0) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

G Medical Innovations Holdings (FRA:9GM0) Headlines

No Headlines